"The future promise of allogeneic cell therapies"
What are the challenges need to be faced in the field of cell therapy? And what would be the role of allogeneic cell therapies in cancer treatments and what are its challenges?
In this podcast, Dr. Jo Brewer, CSO at Adaptimmune, and our President and CTO Stefan Braam discuss the current landscape of adoptive cell therapies.
Listen to learn more about:
- Key differentiators between autologous and allogeneic cell therapies
- How allogeneic cell therapies could resolve many challenges when developing cell therapy
- The role of iPSC in adoptive cell therapy
- The future prospects of these therapies in the field of cancer treatment
